Aspargo Laboratories, Inc.
Company

Aspargo Laboratories, Inc.

Biotechnology Research New, York, United States 39 employees
Employees
39
Contacts
1
Emails
1
Phones
1

Aspargo Laboratories, Inc. Overview

Headquarters
New, York, United States
Website
aspargolabs.com
Industry
Biotechnology Research
Employees
39
Founded
2020
Funding
60.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Aspargo Laboratories, Inc.

Aspargo Labs, Inc., is focused on converting the world’s most meaningful medications into liquid oral suspensions delivered via a proprietary, digitally connected device. Aspargo Labs’ suspension technology offers several key advantages, including improved absorption, ease of administration, flexible dosing, and improved patient adherence. Aspargo is leveraging its unique technology platform to transform a wide range of medications across various therapeutic areas. The initial focus is a liquid oral sildenafil suspension currently marketed by Aspargo in multiple countries.

Aspargo Laboratories, Inc. Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage
Phone contacts
1
25.0% coverage

Aspargo Laboratories, Inc. Org Chart

Sample employees and titles
Name Title Contact
Mario Guralnik, Phd
View
Marc Van Unen, Msc (Econ) Dba Gm Germany, Business Mentor, Educator
View
Harold D. Tamayo CFO, Board Director, Corporate Advisor
View
Andrew Chamlin Chief Marketing Officer - Aspargo Labs
Email Phone

Employees by Management Level

Executive 2 profiles
Individual contributor 1 profile

Compare Similar Companies to Aspargo Laboratories, Inc.